| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $19.9M | +39.4% |
| R&D Expense | $18.6M | +124.5% |
| SG&A Expense | $26.6M | +15.9% |
| Operating Income | -$85.8M | -174.8% |
| Interest Expense | $21K | -76.4% |
| Pre-tax Income | -$84.4M | -177.3% |
| Income Tax | -$987K | +74.2% |
| Net Income | -$83.1M | -210.3% |
| EPS (Basic) | -$1.67 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.9M | -92.5% |
| Accounts Receivable | $3.2M | +176.0% |
| Inventory | $2.0M | +66.3% |
| Current Assets | $9.3M | -69.8% |
| Total Assets | $83.8M | -33.4% |
| Current Liabilities | $15.4M | +11.7% |
| Total Liabilities | $34.5M | +39.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$39.6M | -119.7% |
| Investing Cash Flow | -$8.4M | +82.3% |
| Financing Cash Flow | $23.9M | -66.4% |
| -153.0% |
| Stockholders' Equity |
| $49.3M |
| -51.2% |